Claris Lifesciences has galloped 16% to Rs 229 in early morning deals on the Bombay Stock Exchange (BSE) on back of multiple block deals.
At 0920 hours, around 39 million shares representing 60% of the total equity capital of the pharmaceutical company have changed hands on the counter.
According to information available on BSE website, about 28 million shares have changed hands at price of Rs 216, 7 million shares executed at Rs 218.50 and 2 million shares was executed at price of Rs 221 per share.
The name of the buyers and sellers are not immediately known.
The promoters along with Arjun S. Handa held 60.21% stake or 38.42 million shares in the company. Foreign institutional investors held 14.77% holding and domestic institutional investors held 11.42% stake, while the remaining 13.6% holdings are with the individual shareholders and others.
At 0920 hours, around 39 million shares representing 60% of the total equity capital of the pharmaceutical company have changed hands on the counter.
According to information available on BSE website, about 28 million shares have changed hands at price of Rs 216, 7 million shares executed at Rs 218.50 and 2 million shares was executed at price of Rs 221 per share.
The name of the buyers and sellers are not immediately known.
The promoters along with Arjun S. Handa held 60.21% stake or 38.42 million shares in the company. Foreign institutional investors held 14.77% holding and domestic institutional investors held 11.42% stake, while the remaining 13.6% holdings are with the individual shareholders and others.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%